血清标志物BAGE5、RUNX1T1、SLFN14对比CA19-9在胰腺癌诊断中的比较研究：一项全面评估其临床应用前景的综述Comparative Study of Serum Biomarkers BAGE5, RUNX1T1, SLFN14 in Comparison to CA19-9 for the Diagnosis of Pancreatic Cancer: A Comprehensive Review Assessing Their Clinical Application Prospects
王宏基, 谭云波, 金礼权 科研立项经费支持
临床医学进展Vol.14 No.3, 全文下载: PDF HTML XML DOI:10.12677/ACM.2024.143786, March 20 2024
基于常规血液标志物的早期胰腺癌诊断模型Diagnostic Model for Early Pancreatic Cancer Based on Routine Blood Biomarkers
李晓云, 齐贞光, 荆 雪
临床医学进展Vol.15 No.4, 全文下载: PDF XML DOI:10.12677/acm.2025.1541285, April 28 2025
CA19-9与非小细胞肺癌预后的相关性Association of CA19-9 with Prognosis of Non-Small Cell Lung Cancer
热哈提·阿曼交尔, 刘春玲
临床医学进展Vol.14 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2024.141081, January 15 2024
miR-21 与胰腺癌miR-21 and Pancreatic Cancer
张莉娜, 张弘
世界肿瘤研究Vol.3 No.1, 全文下载: PDF HTML XML DOI:10.12677/WJCR.2013.31001, May 6 2013
血清CA19-9异常增高的胆总管结石7例诊治体会Experience of Diagnosis and Treatment of 7 Cases of Common Bile Duct Stones with Abnormal Increase of Serum CA19-9
刘立民, 张宗明, 刘 卓, 张 翀, 于宏伟, 刘子旭, 朱明文, 宋蒙蒙, 赵 月
外科Vol.6 No.1, 全文下载: PDF HTML XML DOI:10.12677/HJS.2017.61002, January 10 2017
胰腺癌免疫治疗研究进展及临床应用前景探讨Research Progress and Clinical Application Prospect of Immunotherapy for Pancreatic Cancer
闫星宇, 牛 蒙
临床医学进展Vol.14 No.8, 全文下载: PDF XML DOI:10.12677/acm.2024.1482359, August 27 2024